EN
Thyroid cancer treatment in Germany usually means surgery, radioactive iodine for the papillary and follicular forms, and drugs for advanced stages. Most people arrive with an ultrasound report mentioning a “suspicious nodule”, and with anxiety, although most thyroid nodules are benign. Treatment therefore starts with knowing exactly which tumour it is.
Below: the forms, surgery and radioactive iodine, stage 4, anaplastic cancer, hospitals and arrangements. Benign nodules, goitre and hormone disorders are covered under thyroid treatment in Germany.
Types of thyroid cancer and how the diagnosis is confirmed
Thyroid cancer has four main forms, and the form shapes almost the whole treatment plan. Papillary and follicular cancer, the commonest, are differentiated: their cells resemble normal thyroid cells and take up iodine. Medullary cancer arises from calcitonin-producing cells and is sometimes inherited, so relatives are offered a genetic test. Anaplastic cancer is rare and fast-growing.
Diagnosis proceeds step by step: neck ultrasound, blood tests for TSH, T3 and T4, then the key step, an ultrasound-guided fine-needle biopsy showing whether the nodule is benign. Scintigraphy, CT or MRI and molecular testing of the tissue are added where needed, chosen for the individual case.
Surgery and radioactive iodine
Surgery is the main treatment: one lobe or the whole gland is removed (lobectomy or total thyroidectomy), with neck lymph nodes if needed. Nerve monitoring protects the voice nerve, and the calcium-regulating parathyroid glands are preserved. After complete removal a daily hormone tablet follows. In some tumours its dose also keeps TSH, the pituitary hormone driving thyroid cells, low, so remaining tumour cells get fewer growth signals. The endocrinologist sets the TSH target by risk and reviews it over time. Follow-up means thyroglobulin blood tests, a marker of remaining tissue after complete removal, and neck ultrasound as scheduled at discharge.
Radioactive iodine is used for the differentiated forms, usually after surgery. It acts selectively, because mainly thyroid cells and tumours grown from them take up iodine. In Germany it means a stay of a few days on a nuclear medicine ward, as radiation protection rules require. For preparation and procedure, see radioiodine therapy.
Medullary cancer does not take up iodine, so surgery remains its mainstay. German specialists follow the German thyroid cancer guideline in the AWMF register, which spans diagnosis to follow-up and names surgery as the main treatment. A board of endocrinologist, surgeon, nuclear medicine specialist and oncologist decides.
Stage 4 thyroid cancer
Stage 4 means the tumour has grown deep into the neck, towards the spine or around the carotid artery, or has spread to distant organs such as the lungs or bones. In differentiated cancer, patients under 55 are never staged above stage II under the TNM system, so stage 4 mostly concerns older patients and aggressive forms; anaplastic cancer is always stage 4.
Treatment hinges on whether metastases still take up iodine. While they do, radioactive iodine continues; when they stop, tyrosine kinase inhibitors, tablets that block tumour growth signals, are used. BRAF, RET or NTRK mutations can be matched with specific drugs: this is targeted therapy. Single metastases may be irradiated or removed. Once the disease has reached the lungs or bones, treatment usually cannot cure it but can hold it back and ease symptoms.
Immunotherapy is rarely used in thyroid cancer, mostly within clinical trials or combined with targeted drugs.
Anaplastic thyroid cancer
Anaplastic thyroid cancer grows within weeks, so tests and the tumour board decision should take days, not weeks. It is the rarest and most aggressive form and has usually spread within the neck by diagnosis.
The tumour is tested urgently for a BRAF mutation. If present, the targeted drugs dabrafenib and trametinib may be combined, sometimes before surgery to shrink the tumour enough to remove it. Radiotherapy to the neck is also used. The outlook is serious, and doctors discuss goals openly. Send documents immediately rather than waiting for every test at home.
Where thyroid cancer is treated in Germany
Thyroid cancer in Germany is treated by endocrine surgeons working with nuclear medicine departments. In Hamburg, Dr Lena Eckert-Schrage heads the endocrine surgery section at the Israelite Hospital. Prof. Ayman Agha heads visceral and endocrine surgery at Munich Bogenhausen Hospital, where thyroid surgery, including minimally invasive and robotic operations, is a core focus. Prof. Helmut Friess directs the Department of Surgery at Rechts der Isar Hospital in Munich, which includes thyroid and parathyroid surgery.
Radioactive iodine and follow-up belong to nuclear medicine. At Charité in Berlin the nuclear medicine department is headed by Prof. Winfried Brenner, at Klinikum Stuttgart by Prof. Christoph Rischpler. Close teamwork between surgeon and nuclear medicine matters more than the city.
Frequently asked questions
Can thyroid cancer be cured?
Yes, in most cases. Most patients with papillary or follicular cancer recover after surgery and, where needed, radioactive iodine. Medullary cancer is treated mainly with surgery. Anaplastic cancer is the hardest to treat, as it grows quickly and responds poorly. The doctor assesses individual chances from the test results.
Will I need hormone tablets for the rest of my life?
If the whole thyroid has been removed, yes: no tissue is left to make the hormone, so a tablet is taken daily for life. The endocrinologist adjusts the dose with TSH tests, keeping TSH below normal if certain risk factors apply. The tablets are usually well tolerated. After removal of one lobe, blood tests decide.
What happens if thyroid cancer comes back?
Treatment is planned afresh: it may mean another neck operation, sometimes with radioactive iodine, or radioactive iodine alone if the tumour shows up only on an iodine scan. When it no longer takes up iodine, radiotherapy and targeted drugs are considered. Regular thyroglobulin tests and neck ultrasound help catch a recurrence early.
How AlenMed arranges thyroid cancer treatment
AlenMed starts with your documents: ultrasound report, biopsy result, hormone and calcitonin tests and any surgical and histology reports. They are translated and sent to endocrine surgeons and nuclear medicine departments across Germany. If surgery has been recommended at home, discuss its extent with a German surgeon first, not afterwards.
Costs depend on whether surgery, radioactive iodine, radiotherapy or drugs are needed, and for how long; the exact amount comes from the hospital’s cost estimate (Kostenvoranschlag) after document review. What makes up cancer treatment costs in Germany is explained separately. AlenMed also arranges the visa invitation, interpreter and accommodation; its office is in Munich, partner hospitals are all over Germany.
For information only, not an offer: the treatment plan is set by a doctor at an in-person consultation.
News on this topic
Charité treats first beta-thalassemia patient with CRISPR
At Berlin Charité, a 19-year-old beta-thalassemia patient became the first in Germany to receive the newly approved CRISPR gene therapy Exagamglogene Autotemcel.
Real-World Breast Cancer Study Confirms High Five-Year Survival Rates in Germany
A landmark study of over 43,000 German patients reveals a five-year invasive disease-free survival rate of 82.9 percent in early hormone receptor-positive breast cancer.
FDA Approves Jülich Diagnostic Radiotracer FET for Brain Tumor Imaging
The FDA approves the diagnostic radiotracer FET (Pixclara®) for evaluating brain gliomas, highlighting decades of neuro-oncology research at Forschungszentrum Jülich.
